Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-28 @ 5:14 AM
Study NCT ID:
NCT02961257
Status:
COMPLETED
Last Update Posted:
2022-05-12
First Post:
2016-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel
Sponsor:
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-02
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-22
First Submit QC Date:
None
Study First Post Date:
2016-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-09
Last Update Post Date:
2022-05-12
Last Update Post Date Type:
ACTUAL